The SOON.SW stock is trading CHF201.10 in pre-market trade on 11 Mar 2026, up 5.84% on a 293,280 share print versus a 50-day average of 161,714. The jump follows above-average volume and a move off the session low, putting Sonova Holding AG on the scanner in Switzerland (SIX). We flag intraday liquidity and technical momentum for traders while tying the move to Sonova’s valuation and near-term catalysts in this high-volume movers note by Meyka AI.
Pre-market price action for SOON.SW stock
Price moved to CHF201.10, a CHF11.10 rise from yesterday’s close of CHF190.00 and a 5.84% gain. The session range is CHF193.50–CHF204.90 with an open at CHF194.85. Volume is 293,280, a relative volume of 1.81, signaling heavier-than-normal trading and increased short-term liquidity on SIX Switzerland.
Fundamentals and valuation snapshot
Sonova Holding AG shows EPS CHF8.71 and a trailing P/E of 23.09, with market cap about CHF11.99B. Key ratios include P/S 3.12, P/B 4.94, dividend per share CHF4.40 (yield 2.19%) and payout ratio 0.50. These metrics position SOON.SW stock below some healthcare peers on growth but above peers on price-to-book.
Technical read and high-volume trading signals
Momentum indicators are mixed: RSI 51.44, MACD histogram slightly positive, and ADX 32.69 indicating a strong trend. The 50-day MA is CHF206.45 and the 200-day MA is CHF220.59, so the price remains below both moving averages. Bollinger mid at CHF197.15 and ATR CHF5.87 suggest intraday room to trade; On-Balance Volume (OBV 71,256) confirms buying pressure alongside the volume spike.
Meyka AI rates SOON.SW with a score out of 100
Meyka AI rates SOON.SW with a score out of 100: 78 (B+, BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The score reflects strong cash flow metrics, ROE 20.45%, and manageable leverage with debt-to-equity 0.76. Meyka AI’s forecast model projects a 12-month target of CHF222.59, implying 10.68% upside vs the current CHF201.10. Forecasts are model-based projections and not guarantees.
Risks, catalysts and earnings timeline
Risks include margin pressure in certain regions, high intangibles on the balance sheet, and exposure to consumer healthcare spending. Net debt-to-EBITDA is 1.52, which is moderate but warrants monitoring. Catalysts are product updates from Phonak and Advanced Bionics, Sennheiser consumer integrations, and the next earnings report on 2026-05-18. These items can drive volatility and re-rate SOON.SW stock.
Sector context and trading action
Healthcare on SIX shows avg P/E 30.19; Sonova’s P/E 23.09 is below sector average, offering a relative value angle. Sector YTD is down roughly -1.99%, which frames Sonova’s move as stock-specific rather than sector-wide. For market context see recent Swiss market commentary on investing.com and regional stock updates source and source. See Sonova on Meyka for live data: Sonova SOON.SW on Meyka.
Final Thoughts
SOON.SW stock’s pre-market pop to CHF201.10 on 11 Mar 2026 is a clear high-volume mover on SIX. The immediate move is backed by a near-doubling of typical intraday flow (volume 293,280 vs avg 161,714) and a positive short-term technical read (ADX 32.69, MACD histogram positive). From a fundamentals view, Sonova’s P/E 23.09, EPS 8.71, and dividend CHF4.40 support a mixed but constructive picture. Meyka AI’s model target of CHF222.59 implies 10.68% upside versus current price; the 3‑year and 5‑year model paths are CHF193.30 and CHF163.74 respectively, showing potential medium-term variability. Traders should weigh short-term momentum against valuation and the upcoming earnings date 2026-05-18. This is a tradeable high-volume setup for active traders while longer-term investors should monitor margin recovery and product catalysts before adjusting position sizing. Forecasts are model-based and not guarantees, and Meyka AI provides these figures as data-driven analysis, not investment advice.
FAQs
What drove SOON.SW stock higher in pre-market trade?
Pre-market gains were driven by a 5.84% price move to CHF201.10 on above-average volume (293,280 vs avg 161,714). The spike suggests active buying and short-term liquidity rather than broad sector strength.
What is Meyka AI’s price forecast for SOON.SW stock?
Meyka AI’s forecast model projects a 12-month target of CHF222.59 for SOON.SW stock, implying 10.68% upside from CHF201.10. Forecasts are model-based projections and not guarantees.
What are key valuation metrics for Sonova (SOON.SW)?
Key metrics: P/E 23.09, EPS 8.71, P/S 3.12, P/B 4.94, dividend CHF4.40 (yield 2.19%). These show moderate valuation versus the healthcare sector.
When is Sonova’s next earnings announcement and why does it matter?
Sonova reports next on 2026-05-18. The release can confirm margin trends, update guidance and trigger volume-led moves in SOON.SW stock as traders reset expectations.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)